Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer's disease
Hajar Karimi Askarani, Aida Iraji, Arezoo Rastegari, et al.
BMC Chemistry (2020) Vol. 14, Iss. 1
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Inhibitory potential of nitrogen, oxygen and sulfur containing heterocyclic scaffolds against acetylcholinesterase and butyrylcholinesterase
Rami J. Obaid, Nafeesa Naeem, Ehsan Ullah Mughal, et al.
RSC Advances (2022) Vol. 12, Iss. 31, pp. 19764-19855
Open Access | Times Cited: 79
An Overview of 1,2,3-triazole-Containing Hybrids and Their Potential Anticholinesterase Activities
Shah Alam Khan, Mohammad Jawaid Akhtar, Urvashee Gogoi, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 2, pp. 179-179
Open Access | Times Cited: 45
The 1,2,3-triazole ‘all-in-one’ ring system in drug discovery: a good bioisostere, a good pharmacophore, a good linker, and a versatile synthetic tool
Deniz Lengerli, Kübra İbiş, Yahya Nural, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 11, pp. 1209-1236
Closed Access | Times Cited: 51
Multiple roles of fucoxanthin and astaxanthin against Alzheimer's disease: Their pharmacological potential and therapeutic insights
Najmeh Oliyaei, Marzieh Moosavi‐Nasab, Nader Tanideh, et al.
Brain Research Bulletin (2022) Vol. 193, pp. 11-21
Open Access | Times Cited: 35
Cinnamic acid conjugated with triazole acetamides as anti-Alzheimer and anti-melanogenesis candidates: an in vitro and in silico study
Amir Shervin Shokouhi Asl, Mohammad Hosein Sayahi, Mohammad Hashem Hashempur, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Analysis of skeletal diversity of multi-target directed ligands (MTDLs) targeting Alzheimer’s disease
Uzma Azam, Muhammad Moazzam Naseer, Christophe Rochais
European Journal of Medicinal Chemistry (2025) Vol. 286, pp. 117277-117277
Open Access
NOVEL HETEROCYCLIC HYBRIDS AS PROMISING SCAFFOLD FOR THE MANAGEMENT OF ALZHEIMER’S DISEASE
Tyagi Alka
International Journal of Pharmacy and Pharmaceutical Sciences (2025), pp. 1-15
Open Access
Diclofenac derivatives as concomitant inhibitors of cholinesterase, monoamine oxidase, cyclooxygenase-2 and 5-lipoxygenase for the treatment of Alzheimer's disease: synthesis, pharmacology, toxicity and docking studies
Muhammad Aamir Javed, Saba Bibi, Muhammad Saeed Jan, et al.
RSC Advances (2022) Vol. 12, Iss. 35, pp. 22503-22517
Open Access | Times Cited: 26
The anti-Alzheimer potential of novel spiroindolin-1,2-diazepine derivatives as targeted cholinesterase inhibitors with modified substituents
Hormoz Pourtaher, Alireza Hasaninejad, Shahrokh Zare, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 14
Pathogenesis of Alzheimer’s Disease and Diversity of 1,2,3-Triazole Scaffold in Drug Development: Design Strategies, Structural Insights, and Therapeutic Potential
Atamjit Singh, Karanvir Singh, Jashandeep Kaur, et al.
ACS Chemical Neuroscience (2023) Vol. 14, Iss. 18, pp. 3291-3317
Closed Access | Times Cited: 12
Synthesis and bio-evaluation of new multifunctional methylindolinone-1,2,3-triazole hybrids as anti-Alzheimer's agents
Mina Saeedi, Atefeh Maleki, Aida Iraji, et al.
Journal of Molecular Structure (2020) Vol. 1229, pp. 129828-129828
Closed Access | Times Cited: 34
A comprehensive review on triazole based conjugates as acetylcholinesterase inhibitors: Design strategies, synthesis, biological activity, structure activity relationships, molecular docking studies
Harmandeep Kaur Gulati, Nitish Kumar, Anchal Sharma, et al.
Journal of Molecular Structure (2023) Vol. 1284, pp. 135354-135354
Closed Access | Times Cited: 11
Design, synthesis, and biological evaluation of novel (4-(1,2,4-oxadiazol-5-yl)phenyl)-2-aminoacetamide derivatives as multifunctional agents for the treatment of Alzheimer's disease
Tongtong Liu, Shiming Chen, Jiyu Du, et al.
European Journal of Medicinal Chemistry (2021) Vol. 227, pp. 113973-113973
Closed Access | Times Cited: 26
Synthesis and evaluation of novel arylisoxazoles linked to tacrine moiety: in vitro and in vivo biological activities against Alzheimer’s disease
Arezoo Rastegari, Maliheh Safavi, Fahimeh Vafadarnejad, et al.
Molecular Diversity (2021) Vol. 26, Iss. 1, pp. 409-428
Closed Access | Times Cited: 22
Recent advance on pleiotropic cholinesterase inhibitors bearing amyloid modulation efficacy
Honghua Zhang, Yan Peng, Linsheng Zhuo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 242, pp. 114695-114695
Closed Access | Times Cited: 15
Binding studies of potential amyloid-β inhibiting chalcone derivative with bovine serum albumin
Shivani Daksh, Chandraprakash Gond, Nikhil Kumar, et al.
Spectrochimica Acta Part A Molecular and Biomolecular Spectroscopy (2023) Vol. 305, pp. 123362-123362
Closed Access | Times Cited: 8
The Effects of Astaxanthin on Cognitive Function and Neurodegeneration in Humans: A Critical Review
Callum James Joshua Queen, S. Andy Sparks, David Marchant, et al.
Nutrients (2024) Vol. 16, Iss. 6, pp. 826-826
Open Access | Times Cited: 2
Amino-7,8-dihydro-4H-chromenone derivatives as potential inhibitors of acetylcholinesterase and butyrylcholinesterase for Alzheimer’s disease management; in vitro and in silico study
Ali Asadipour, Yaghoub Pourshojaei, Moein Mansouri, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access | Times Cited: 2
Synthesis, biological evaluation and molecular modeling studies of methyl indole-isoxazole carbohydrazide derivatives as multi-target anti-Alzheimer’s agents
Aida Iraji, Parisa Nikfar, Mohammad Nazari Montazer, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Click-designed vanilloid-triazole conjugates as dual inhibitors of AChE and Aβ aggregation
Marwa Elsbaey, Yasuhiro Igarashi, Mahmoud A. A. Ibrahim, et al.
RSC Advances (2023) Vol. 13, Iss. 5, pp. 2871-2883
Open Access | Times Cited: 7
Novel N′-substituted benzylidene benzohydrazides linked to 1,2,3-triazoles: potent α-glucosidase inhibitors
Mina Saeedi, Roshanak Hariri, Aida Iraji, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 7
Synthesis, and in vitro biological evaluations of novel naphthoquinone conjugated to aryl triazole acetamide derivatives as potential anti-Alzheimer agents
Samanesadat Hosseini, Seied Ali Pourmousavi, Mohammad Mahdavi, et al.
Journal of Molecular Structure (2021) Vol. 1255, pp. 132229-132229
Closed Access | Times Cited: 14
An overview of structure-based activity outcomes of pyran derivatives against Alzheimer’s disease
Faisal A. Almalki
Saudi Pharmaceutical Journal (2023) Vol. 31, Iss. 6, pp. 998-1018
Open Access | Times Cited: 5
Synthesis of novel hybrids of 1,2,3-triazoles-hydrazone: targeting cholinesterases and Alzheimer's related genes
Diba Shareghi-Boroujeni, Aida Iraji, Mahintaj Dara, et al.
Future Medicinal Chemistry (2024) Vol. 16, Iss. 15, pp. 1519-1535
Closed Access | Times Cited: 1
Repurposing Anidulafungin for Alzheimer’s Disease via Fragment-Based Drug Discovery
Siqi Xie, Yumei Liang, Yang Song, et al.
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 16, pp. 2995-3008
Open Access | Times Cited: 1
Page 1 - Next Page

Scroll to top